CBSET Logo
Connect with Us
  • Home
  • About CBSET
    • Company
    • Leadership
    • CBSET Mission, Vision & Culture
    • Careers & Internships
    • Facilities & Equipment
    • Education & Training
  • Services
    • Medical Device Testing
    • Drug & Cell-based Therapies
    • Histopathology & Morphometry
    • Auditory Safety & Efficacy Services
    • Physician Training
  • Focus Areas
    • Sympathetic Denervation
    • Coronary Artery Disease (CAD)
    • Peripheral Artery Disease (PAD)
    • Drug-Coated Balloons
    • Thrombectomy & Thrombolysis
    • Bone & Joint Health
    • Oncology
  • Library
    • Scientific Publications and Presentations
    • Brochures & Flyers
  • Newsroom
    • News and Events
    • Event Archives
  • Contact
  • Menu

TCT 2005: Total Paclitaxel Dose Optimization With Minimized Abluminal Bioerodable Polymer Stent Coatings Provides Safe Delivery of Paclitaxel in Porcine Coronary Arteries

Spognardi AM. ‘Total Paclitaxel Dose Optimization With Minimized Abluminal Bioerodable Polymer Stent Coatings Provides Safe Delivery of Paclitaxel in Porcine Coronary Arteries.’

Transcatheter Cardiovascular Therapeutics, Washington, DC, 2005.



Explore Our Services

  • Medical Device Testing
  • Drug & Cell-based Therapies
  • Histopathology & Morphometry
  • Auditory Safety & Efficacy Services
  • Physician Training
Company FAQ

GET IN TOUCH WITH US

CBSET, Inc.
500 Shire Way
Lexington, MA 02421 USA
info@cbset.com
+1 781 541 5555

QUICK LINKS

  • Home
  • Contact CBSET
  • CBSET Services
  • Privacy

FOLLOW US

olaw logo
massmedic logo
massdevice logo
massbio logo
aaalac logo

Copyright CBSET. All rights reserved.